Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: The William Beaumont Phase II dose-escalating trial

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 2, 2000, Pages 343-352

  Martinez, Alvaro A ^a   Kestin, Larry L ^a   Stromberg, Jannifer S ^a   Gonzalez, Jose A ^a   Wallace, Michelle ^a   Gustafson, Gary S ^a   Edmundson, Gregory K ^a   Spencer, William ^a   Vicini, Frank A ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Brachytherapy; Image guided; Prostate; Prostate specific antigen; Prostatic neoplasms; Radiotherapy

Indexed keywords

IRIDIUM 192; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RADIATION DOSE; SCORING SYSTEM; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRACHYTHERAPY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL;

EID: 0034193185     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00436-3     Document Type: Article

References (72)

1. Landis S.H., Murray T., Bolden S., et al. Cancer statistics, 1999. CA Cancer J Clin. 49:1999;8-31.
2. George N.J. Natural history of localised prostate cancer managed by conservative therapy alone. Lancet. 1:1988;494-497.
3. Zincke H., Fleming T.R., Furlow W.L., et al. Radical retropubic prostatectomy and pelvic lymphadenectomy for high-stage cancer of the prostate. Cancer. 47:1981;1901-1910.
4. Paulson D.F., Moul J.W., Walther P.J., et al. Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma Long-term results . J Urol. 144:1990;1180-1184.
5. Pilepich M.V., Bagshaw M.A., Asbell S.O., et al. Definitive radiotherapy in resectable (stage A2 and B) carcinoma of the prostate Results of a nationwide overview . Int J Radiat Oncol Biol Phys. 13:1987;659-663.
6. Perez C.A., Pilepich M.V., Zivnuska F. Tumor control in definitive irradiation of localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 12:1986;523-531.
7. Hanks G.E., Diamond J.J., Krall J.M., et al. A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States. Int J Radiat Oncol Biol Phys. 13:1987;499-505.
8. Blackard C.E. The Veterans' Administration Cooperative Urological Research Group studies of carcinoma of the prostate A review . Cancer Chemother Rep. 59:1975;225-227.
9. Smith J.A. Jr. New methods of endocrine management of prostatic cancer. J Urol. 137:1987;1-10.
10. Pilepich M.V., Bagshaw M.A., Asbell S.O., et al. Radical prostatectomy or radiotherapy in carcinoma of prostate The dilemma continues . Urology. 30:1987;18-21.
11. Paulson D.F., Lin G.H., Hinshaw W., et al. Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol. 128:1982;502-504.
12. Martinez AA, Gonzalez JA, Chung AK; et al. A comparison of external beam radiation therapy versus radical prostatectomy in patients with low-risk prostate cancer diagnosed, staged, and treated at a single institution. Cancer. In press.
13. Perez C.A. Prostate. Perez C.A., Brady L.W. Principles and practice of radiation oncology. 3rd ed. 1997;1583-1694 Lippincott-Raven, Philadelphia.
14. Leach G.E., Cooper J.F., Kagan A.R., et al. Radiotherapy for prostatic carcinoma Post-irradiation prostatic biopsy and recurrence patterns with long-term followup . J Urol. 128:1982;505-509.
15. Kabalin J.N., Hodge K.K., McNeal J.E., et al. Identification of residual cancer in the prostate following radiation therapy Role of transrectal ultrasound guided biopsy and prostate specific antigen . J Urol. 142:1989;326-331.
16. Cox J.D., Kline R.W. Do prostatic biopsies 12 months or more after external irradiation for adenocarcinoma, Stage III, predict long-term survival? Int J Radiat Oncol Biol Phys. 9:1983;299-303.
17. Scardino P.T., Frankel J.M., Wheeler T.M., et al. The prognostic significance of post-irradiation biopsy results in patients with prostatic cancer. J Urol. 135:1986;510-516.
18. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 43:1998;491-500.
19. Hanks G.E., Martz K.L., Diamond J.J. The effect of dose on local control of prostate cancer. Int J Radiat Oncol Biol Phys. 15:1988;1299-1305.
20. Hendry J.H., Moore J.V. Is the steepness of dose-incidence curves for tumour control or complications due to variation before, or as a result of, irradiation? Br J Radiol. 57:1984;1045-1046.
21. Beard C.J., Kijewski P., Bussiere M., et al. Analysis of prostate and seminal vesicle motion Implications for treatment planning . Int J Radiat Oncol Biol Phys. 34:1996;451-458.
22. Melian E., Mageras G.S., Fuks Z., et al. Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. Int J Radiat Oncol Biol Phys. 38:1997;73-81.
23. Brabbins D.S., Yan D., Lockman D., et al. Treatment of prostate cancer using a proactive decision-making process. (abstr) Radiother Oncol. 48:(Suppl. 1):1998;23.
24. Yan D., Ziaja E., Jaffray D., et al. The use of adaptive radiation therapy to reduce setup error A prospective clinical study . Int J Radiat Oncol Biol Phys. 41:1998;715-720.
25. Stromberg J., Martinez A., Gonzalez J., et al. Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer Treatment description and preliminary results of a phase I/II clinical trial . Int J Radiat Oncol Biol Phys. 33:1995;161-171.
26. Martinez A., Benson R.C., Edmundson G.K., et al. Pelvic lymphadenectomy combined with transperineal interstitial implantation of iridium-192 and external beam radiotherapy for locally advanced prostatic carcinoma Technical description . Int J Radiat Oncol Biol Phys. 11:1985;841-847.
27. Stromberg J., Martinez A., Benson R., et al. Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation. Int J Radiat Oncol Biol Phys. 28:1994;171-177.
28. Holm H.H., Juul N., Pedersen J.F., et al. Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol. 130:1983;283-286.
29. Ragde H., Blasko J.C., Grimm P.D., et al. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer. 80:1997;442-453.
30. Priestly J.B., Beyer D.C. Guided brachytherapy for treatment of confined prostate cancer. Urology. 40:1992;27-32.
31. Edmundson G.K., Rizzo N., Teahan M., et al. Concurrent treatment planning for outpatient high dose rate prostate template implants. Int J Radiat Oncol Biol Phys. 27:1993;1215-1223.
32. Edmundson G.K., Yan D., Martinez A. Intraoperative optimization of needle placement and dwell times for conformal prostate brachytherapy. Int J Radiat Oncol Biol Phys. 33:1995;1257-1263.
33. Edmundson G.K. Geometry based optimization for stepping source implants. Martinez A.A., Orton C.G., Mould R.F. Brachytherapy HDR and LDR. 1990;184-192 Nucletron, Columbia, MD.
34. Gustafson G., Edmundson G.K., Vicini F., et al. Overcoming internal prostate motion and set-up inaccuracies with conformal interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 32:(Suppl.):1995;199.
35. American Joint Committee on Cancer. Prostate. In: Beahrs OH, Henson DE, Hutter RVP; et al., editors, AJCC cancer staging manual. 4th ed. Philadelphia: Lippincott-Raven; 1993. p. 189-193.
36. Martinez A.M., Gonzalez J., Stromberg J., et al. Conformal prostate brachytherapy Initial experience of a phase I/II dose-escalating trial . Int J Radiat Oncol Biol Phys. 33:1995;1019-1027.
37. Stromberg J.S., Martinez A.A., Horwitz E.M., et al. Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer Superior prostate-specific antigen response compared with external beam treatment . Cancer J Sci Am. 3:1997;346-352.
38. Barendsen G.W. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys. 8:1982;1981-1997.
39. Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:1035-1041.
40. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
41. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 50:1966;163-170.
42. Cox D.R. Regression models and life-tables. J R Stat Soc B. 34:1972;187-220.
43. Brenner D.J., Hall E.J. Fractionation and protraction of radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 43:1999;1095-1101.
44. Fukunaga-Johnson N., Sandler H.M., McLaughlin P.W., et al. Results of 3D conformal radiotherapy in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys. 38:1997;311-317.
45. Hanks G.E., Hanlon A.L., Pinover W.H., et al. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. Cancer J Sci Am. 5:1999;152-158.
46. Hanks G.E., Hanlon A.L., Schultheiss T.E., et al. Dose escalation with 3D conformal treatment Five year outcomes, treatment optimization, and future directions . Int J Radiat Oncol Biol Phys. 41:1998;501-510.
47. Hanks G.E., Lee W.R., Hanlon A.L., et al. Conformal technique dose escalation for prostate cancer Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen > 10 ng/ml . Int J Radiat Oncol Biol Phys. 35:1996;861-868.
48. Hanks GE, Schultheiss TE, Hanlon AL; et al. Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study. Int J Radiat Oncol Biol Phys 1997;37:543-510.
49. Pollack A., Zagars G.K. External beam radiotherapy for stage T1/T2 prostate cancer How does it stack up? Urology. 51:1998;258-264.
50. Roach M., Meehan S., Kroll S., et al. Radiotherapy for high grade clinically localized adenocarcinoma of the prostate. J Urol. 156:1996;1719-1723.
51. Zelefsky M.J., Fuks Z., Wolfe T., et al. Locally advanced prostate cancer Long-term toxicity outcome after three-dimensional conformal radiation therapy: A dose escalation study . Radiology. 209:1998;169-174.
52. Forman J.D., Duclos M., Sharma R., et al. Conformal mixed neutron and photon irradiation in localized and locally advanced prostate cancer Preliminary estimates of the therapeutic ratio . Int J Radiat Oncol Biol Phys. 35:1996;259-266.
53. Forman J.D., Porter A.T. The experience with neutron irradiation in locally advanced adenocarcinoma of the prostate. Sem Urol Oncol. 15:1997;239-243.
54. Haraf D.J., Rubin S.J., Sweeney P., et al. Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer. Int J Radiat Oncol Biol Phys. 33:1995;3-14.
55. Forman J.D., Orton C., Ezzell G., et al. Preliminary results of a hyperfractionated dose escalation study for locally advanced adenocarcinoma of the prostate. Radiother Oncol. 27:1993;203-208.
56. Shipley W.U., Verhey L.J., Munzenrider J.E., et al. Advanced prostate cancer The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone . Int J Radiat Oncol Biol Phys. 32:1995;3-12.
57. Yonemoto L.T., Slater J.D., Rossi C.J., et al. Combined proton and photon conformal radiation therapy for locally advanced carcinoma of the prostate Preliminary results of a phase I/II study . Int J Radiat Oncol Biol Phys. 37:1997;21-29.
58. Critz F.A., Levinson A.K., Williams W.H., Holladay D.A. Prostate-specific antigen nadir The optimum level after irradiation for prostate cancer . J Clin Oncol. 14:1996;2893-2900.
59. Stock R.G., Stone N.N., Tabert A., et al. A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys. 41:1998;101-108.
60. Zelefsky M.J., Whitmore W.F., Leibel S., et al. Long-term results of retropubic permanent iodine-125 implantation of the prostate for clinically localized prostate cancer. J Urol. 158:1997;23-30.
61. Kini V.R., Edmundson G.K., Vicini F.A., et al. Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants. Int J Radiat Oncol Biol Phys. 43:1999;571-578.
62. Bolla M., Gonzalez D., Warde P., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med. 337:1997;295-300.
63. Pilepich M.V., Caplan R., Byhardt C.A., et al. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy Report of Radiation Therapy Oncology Group Protocol 85-31 . J Clin Oncol. 15:1997;1013-1021.
64. Mate T.P., Gottesman J.E., Hatton J., et al. High dose-rate afterloading iridium-192 prostate brachytherapy Feasibility report . Int J Radiat Oncol Biol Phys. 41:1998;525-533.
65. Kovacs G, Galalae R. High dose-rate brachytherapy of prostate cancer: German experience. Proceedings of the 9th International Brachytherapy Conference, Palm Springs, CA. Columbia, MD: Nucletron Corporation; 1997. p. 84-85.
66. Paul R., Hofmann R., Schwarzer J.U., et al. Iridium-192 high-dose-rate brachytherapy A useful alternative therapy for localized prostate cancer? World J Urol. 15:1997;252-256.
67. Borghede G., Hedelin H., Holmang S., et al. Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma. Radiother Oncol. 44:1997;237-244.
68. Borghede G., Hedelin H., Holmang S., et al. Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland. Radiother Oncol. 44:1997;245-250.
69. Zeitlin S.I., Sherman J., Raboy A., et al. High dose combination radiotherapy for the treatment of localized prostate cancer. J Urol. 160:1998;91-96.
70. Ragde H., Elgamal A.A., Snow P.B., et al. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-Gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer. 83:1998;989-1001.
71. Dattoli M., Wallner K., Sorace R., et al. Pd 103 brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma. Int J Radiat Oncol Biol Phys. 35:1996;875-879.
72. Kaye K.W., Olson D.J., Payne J.T. Detailed preliminary analysis of iodine 125 implantation for localized prostate cancer using percutaneous approach. J Urol. 153:1995;1020-1025.